Filing Details
- Accession Number:
- 0001179110-19-003505
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-03-07 15:19:02
- Reporting Period:
- 2019-03-07
- Accepted Time:
- 2019-03-07 15:19:02
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1578845 | Allergan Plc | AGN | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1268854 | L Brent Saunders | Clonshaugh Business And Technology Park, Coolock, Co. Dublin L2 D17 E400 | Chairman, President And Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares, Par Value $0.0001 | Acquisiton | 2019-03-07 | 300 | $142.18 | 169,206 | No | 4 | P | Direct | |
| Ordinary Shares, Par Value $0.0001 | Acquisiton | 2019-03-07 | 860 | $143.70 | 170,066 | No | 4 | P | Direct | |
| Ordinary Shares, Par Value $0.0001 | Acquisiton | 2019-03-07 | 600 | $144.37 | 170,666 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct | |
| No | 4 | P | Direct | |
| No | 4 | P | Direct |
Footnotes
- The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $142.09 to $142.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote
- The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $143.13 to $143.91, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
- The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $144.15 to $144.55, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
- Includes restricted stock units issued pursuant to the 2013 Incentive Award Plan of Allergan plc.
Billionaire Hedge Funds
